The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site
about
Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contactsAntigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2Crystal structure of monomeric human -2-microglobulin reveals clues to its amyloidogenic propertiesStructural Basis for T Cell Alloreactivity among Three HLA-B14 and HLA-B27 AntigensStructures of MART-126/27–35 Peptide/HLA-A2 Complexes Reveal a Remarkable Disconnect between Antigen Structural Homology and T Cell RecognitionInsights into MHC Class I Peptide Loading from the Structure of the Tapasin-ERp57 Thiol Oxidoreductase HeterodimerIdentification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A virusesT Cell Receptor Cross-reactivity Directed by Antigen-Dependent Tuning of Peptide-MHC Molecular FlexibilityStructures of native and affinity-enhanced WT1 epitopes bound to HLA-A0201: Implications for WT1-based cancer therapeuticsMHC Class I Bound to an Immunodominant Theileria parva Epitope Demonstrates Unconventional Presentation to T Cell Receptorsβ2-microglobulin forms three-dimensional domain-swapped amyloid fibrils with disulfide linkagesConformational Melding Permits a Conserved Binding Geometry in TCR Recognition of Foreign and Self Molecular MimicsStructure of HLA-A*0301 in complex with a peptide of proteolipid protein: insights into the role of HLA-A alleles in susceptibility to multiple sclerosisT-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen TargetingLoss of T Cell Antigen Recognition Arising from Changes in Peptide and Major Histocompatibility Complex Protein Flexibility: IMPLICATIONS FOR VACCINE DESIGNStructure of an early native-like intermediate of β2-microglobulin amyloidogenesisComputational Design of the Affinity and Specificity of a Therapeutic T Cell ReceptorIdentification of the core regulators of the HLA I-peptide binding processPeptide modulation of class I major histocompatibility complex protein molecular flexibility and the implications for immune recognition.The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A*68:01Major histocompatibility complex class I molecules bind natural peptide ligands lacking the amino-terminal binding residue in vivo.Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin.How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoireSide-chain conformational space analysis (SCSA): a multi conformation-based QSAR approach for modeling and prediction of protein-peptide binding affinities.The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide bindingAmyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases.Structure of the preamyloid dimer of beta-2-microglobulin from covalent labeling and mass spectrometry.Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens.Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.A Structural-informatics approach for tracing beta-sheets: building pseudo-C(alpha) traces for beta-strands in intermediate-resolution density maps.EpicCapo: epitope prediction using combined information of amino acid pairwise contact potentials and HLA-peptide contact site information.A role for UDP-glucose glycoprotein glucosyltransferase in expression and quality control of MHC class I moleculesScrutinizing MHC-I binding peptides and their limits of variationAntigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.EGFR T790M mutation as a possible target for immunotherapy; identification of HLA-A*0201-restricted T cell epitopes derived from the EGFR T790M mutationHuman cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18A comprehensive calorimetric investigation of an entropically driven T cell receptor-peptide/major histocompatibility complex interaction.Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex.
P2860
Q27631018-3CA09E43-4CB0-4399-8BB4-7EB92B494FD3Q27632371-FA6ABB6C-DE34-40C2-9967-C6B9D4B921D8Q27639361-6BB7B7AD-A924-4DF0-BB8A-8608429E2AB2Q27646543-7588ECE1-57F0-403E-A1DB-B226ABFB8369Q27647534-75D244B4-2BBB-4BB3-8923-931E0377D91BQ27653314-1B71C477-AFB3-48A7-8392-FC82177E3838Q27658413-11379872-3D1B-4F39-A231-9F0F5F66F860Q27658913-951C85F8-C7E9-413A-B093-EA544BE104BCQ27663300-2D7740E8-EEDA-4D6A-B2FE-4105F0E7FF8DQ27665375-9C20C2D2-9D5F-4B33-9211-88DB5C319F1EQ27666185-1BA540D0-D87C-4EB9-9D58-0DA620F56DF7Q27666797-1B262279-1952-4BA8-82F3-B5E2E09EF625Q27667717-E19EAC95-3495-4F7A-9876-DD9BA4137127Q27672418-A1A94186-BFEA-42A5-B3C3-EA991134FF68Q27674375-E515F0FD-397C-4DBF-A985-63E0F63A25E3Q27679310-0E146531-F493-4E9D-97D6-4FC32690B801Q27681832-191C0ADF-62EA-4F31-896A-F6A045AC3484Q29048598-903BC4D5-E191-48DD-9C2F-C051C64C0641Q30351955-0EEF5A7C-8B75-49C5-BDB2-CC4E9A76FA9FQ30423203-B3E54CD8-5ACC-4325-AF1E-DB7B9F1C170DQ30718387-05C9FAAF-AA74-4F45-91A7-375A548FA733Q31005351-8557C4F0-660D-4ED6-8661-768900AF203CQ31022562-C267EC25-72EB-4672-86B6-4D22C4A1B0BFQ33362590-9A52554E-C0E8-41B5-9067-C320589E3F87Q33374550-1D04A3D8-E6E7-42EF-BA82-FCD84E94966AQ33419581-4E5F1090-FC74-4896-B132-820FD886B635Q33495551-43BBCCCE-BB86-48A7-A869-7285340CE516Q33765266-664F457D-AF02-4935-AF2A-FD6A19E241F2Q33894929-269C9BAC-8C99-4C21-B66B-5E76FBC69940Q33927547-1E2D8434-A5B6-4EE1-A95B-65E7930190D9Q34106378-9A242E86-3C1E-4FA9-995E-F4CB29F8BD17Q34486583-7E20472E-F8E1-46E1-AB9E-DA643B1E565DQ34720949-06489032-4F5E-4355-914B-46012C5AC20FQ34765261-F68D37D7-1F65-4EE4-92A9-370461195A12Q35005935-E5C57293-A64B-4ABD-85F7-1558D99C96D4Q35040888-F2A2FCC7-9160-4C91-87D5-CD752A7DB3F3Q35828380-DE079E71-B91A-4A72-816A-D291AEA49E0CQ35850974-2B6B8DE5-35DF-445C-BE8A-0DD6A5654DCAQ36032150-9278D603-4BE9-42F6-B1DD-642D606171FBQ36266447-EEED5AC1-1FE4-406B-B60B-753B60FE7A37
P2860
The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The structure and stability of ...... eptide-N-terminal binding site
@ast
The structure and stability of ...... eptide-N-terminal binding site
@en
The structure and stability of ...... eptide-N-terminal binding site
@nl
type
label
The structure and stability of ...... eptide-N-terminal binding site
@ast
The structure and stability of ...... eptide-N-terminal binding site
@en
The structure and stability of ...... eptide-N-terminal binding site
@nl
prefLabel
The structure and stability of ...... eptide-N-terminal binding site
@ast
The structure and stability of ...... eptide-N-terminal binding site
@en
The structure and stability of ...... eptide-N-terminal binding site
@nl
P2093
P3181
P1476
The structure and stability of ...... eptide-N-terminal binding site
@en
P2093
P304
P3181
P356
10.4049/JIMMUNOL.164.12.6398
P407
P577
2000-06-15T00:00:00Z